Professional Documents
Culture Documents
Nuclear Pharmacy
Nuclear Pharmacy
Half-lives of radiopharmaceuticals:
a. Physical half-life: the amount of time necessary for the radioactive
atoms to decay to one half their original number.
b. Biological half-life: the amount of time necessary for the body to
eliminate one half of the administered dose.
c. Effective half-life: the time requred for an administered dose to be
reduced to one half due to both physical decay and biological
elimination.
Optimal radiopharmaceuticals:
1- With half lives short enough to minimize patient exposure yet
long enough to collect imaging information.
2- Incorporate a gamma emitting radionuclide.
3- Localized rapidly in the organ system of interest.
4- Available and cost-effective.
Agent Uses
Chromium phosphate P-32 Peritonial or pleural effusions caused by metastatic
suspension disease & ovarian and prostatic cancer.
Sodium phosphate P-32 Polycythemia rubra vera, metastatic bone pain.
solution
Sodium iodide I-131 Hyperthyoidism and thyroid carcinoma.
Stronium 89Sr chloride & Alleviation of bone pain due to metastatic bone
Samarium-153 lexidronan pain.
Biotechnologic Products
Basic terminology:
Colony-stimulating factors (CSFs): a class of glycoprotein hormones that
regulate the differentiation and formation of blood cells from precursor cells.
Cytokines: a group of special proteins (non antibodies) released by cells to
trigger action in other cells.
Lymphokine: any class of soluble proteins produced by some WBCs and
stimulate other WBCs as part of the immune response.
Tumor necrosis factor (TNF): a lymphokine produced by macrophages. It
can be activated to kill tumor cells.
Interferon: a class of glycoproteins produced by animal cells in response to
viral infection.
Interleukin: a group of proteins synthesized by macrophages and T
lymphocytes in response to antigens and other stimulation.
Drug Indication
Human insulin Diabetes
Somatrem, somatotropin & Human GH deficiency in children
Human growth hormone Short stature.
Interferon-alpha-2a Leukemia & AIDs related Kaposi sarcoma
Interferon-alpha-2b Leukemia & lymphoma
Chronic hepatitis C
Muromonab-CD3 Acute kidney transplant rejection
Daclizumab, Basiliximab Prophylaxis of acute graft rejection after renal
transplantation.
Erythropietin Anaemia associated with CRF, AIDS, zidovudine
administation, chemotherapy & cancer.
Antihemophilic factor Hemophilia
Filgrastim & Sargramostim Bone marrow transplant
Abciximab & Eptifibatide Glycoprotein IIb/IIIa receptor antagonist
Alteplase, Reteplase Thrombolytic
Infliximab Inflammatory bowel diseases & RA.
Etanercept Rheumatoid arthritis (RA).